Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
about
Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Genotoxicity in Mice Following AAV Gene Delivery: A Safety Concern for Human Gene Therapy?Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectorsTALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus.Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodiesGene editing technology as an approach to the treatment of liver diseases.Adeno-Associated Virus Gene Therapy for Liver Disease.Cell and gene therapy strategies to eradicate HIV reservoirsPlasmodium meets AAV-the (un)likely marriage of parasitology and virology, and how to make the match.Current and future prospects for hemophilia gene therapy.Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention.Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genome.AAV Infection: Protection from Cancer.Blocking sense-strand activity improves potency, safety and specificity of anti-hepatitis B virus short hairpin RNA.Development of an AAV9 coding for a 3XFLAG-TALEfrat#8-VP64 able to increase in vivo the human frataxin in YG8R mice.Dystrophin Gene Replacement and Gene Repair Therapy for Duchenne Muscular Dystrophy in 2016: An Interview.Reply to "Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV"Lessons learned from lung and liver in-vivo gene therapy: implications for the futureAAVvector-mediated in vivo reprogramming into pluripotency
P2860
Q33881920-BE35538C-C8A5-4F43-B558-BDDA53BBC8BCQ36756903-655B9A28-7CE8-4A0D-A99C-90480EC5BFD2Q36867801-EEAEBD9A-0196-4822-B49D-B9E849FC6CDAQ37577414-D7061481-8AF3-44D7-8722-1C981878F422Q37621530-70F975D0-9C02-4AD7-A1FC-1BD6660CFA09Q38749884-1DF80D50-5BB0-43C5-A893-F69AD9A82F2CQ38789554-66AF742C-8B68-4E94-A2F7-83E19A147026Q38794293-61B3049C-E86E-4C13-9F84-BB6BEB5AE6DFQ38818422-5D6A4D9F-1B5D-4705-BB05-6E6D26F1598CQ38827606-3C92E584-F6AE-4B9B-90E9-49E203DDD088Q39108774-BDF5F2C8-46D1-4A0B-8D9C-95A8024BFC19Q40154601-C908D62E-CB8E-4B11-8CB5-627E5AD6DCF3Q40457152-D81D2686-806F-4E55-95D7-1512223740ADQ40595052-DE3BA25D-B63B-4C7F-BABD-D70B58081DB5Q40798280-F6E36A20-7385-487C-A26F-64E36513DE72Q42561764-09ADC0E8-4F89-429E-ABC9-A3131647C8F5Q42749763-FD8CFA6A-815B-450E-AA97-2036C3ADE3F0Q57163666-15BEAA26-868C-4ED4-BA61-1ECF32C4DDDEQ57562597-C4C0F07F-FD23-4EA2-BE86-A15EDE45BB4B
P2860
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
@en
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
@nl
type
label
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
@en
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
@nl
prefLabel
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
@en
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
@nl
P2093
P2860
P1433
P1476
Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?
@en
P2093
Arun Srivastava
Barry J Byrne
Guangping Gao
Kenneth I Berns
Nicholas Muzyczka
Roland W Herzog
Sergei Zolotukhin
Terence R Flotte
Thierry VandenDriessche
P2860
P304
P356
10.1089/HUM.2015.29014.KIB
P577
2015-12-01T00:00:00Z